What does MEDISCH KABINET DR. LUC MOENS do?

MEDISCH KABINET DR. LUC MOENS is a specialist medical practice in Opwijk. Private Limited, started on 11 July 2002.

What is the address of MEDISCH KABINET DR. LUC MOENS?

The registered office of MEDISCH KABINET DR. LUC MOENS is located at Nijverseelstraat 137, 1745 Opwijk.

Is MEDISCH KABINET DR. LUC MOENS still active?

Yes. According to the CBE (15 November 2026) MEDISCH KABINET DR. LUC MOENS is active, legal situation “Normale toestand”, started on 11 July 2002.

Is MEDISCH KABINET DR. LUC MOENS registered on Peppol?

No, MEDISCH KABINET DR. LUC MOENS is currently not registered on the Peppol network.

What is the enterprise number of MEDISCH KABINET DR. LUC MOENS?

The enterprise number of MEDISCH KABINET DR. LUC MOENS is BE0477959778.

When was MEDISCH KABINET DR. LUC MOENS founded?

MEDISCH KABINET DR. LUC MOENS was founded on 11 July 2002.

Who are the directors of MEDISCH KABINET DR. LUC MOENS?

According to the 2025 annual accounts, the directors of MEDISCH KABINET DR. LUC MOENS are: Luc Moens.

Is MEDISCH KABINET DR. LUC MOENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 July 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDISCH KABINET DR. LUC MOENS make in 2025?

MEDISCH KABINET DR. LUC MOENS posted a profit after taxes of € 59,238 in financial year 2025.

What is the revenue of MEDISCH KABINET DR. LUC MOENS?

As a small company, MEDISCH KABINET DR. LUC MOENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 116,120.

MEDISCH KABINET DR. LUC MOENS (Private Limited) - Opwijk

Dossier MEDISCH KABINET DR. LUC MOENS, printed on 15 November 2026 from databakkes.be/en/0477959778/medisch-kabinet-dr-luc-moens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MEDISCH KABINET DR. LUC MOENS from Opwijk, company number BE0477959778, closed financial year 2025 with a result of € 59,238 after tax. For that financial year MEDISCH KABINET DR. LUC MOENS recorded a gross margin of € 116,120 and equity of € 574,227. Compared with financial year 2024, the result moved from € 121,685 to € 59,238. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 28, 2026.

What it is worth Healthy

€ 574,227

▼ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 59,238

▼ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 612,933

▲ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 124,472 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 11,572

▼ 14% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go

€ 76,100

▼ 12% vs 2024

€ 11,063 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 11,881

▲ 70% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 19,545

▼ 11% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 199,720 Gross margin 2022: € 199,720 First fiscal year in the series	€ 95,932 Gross margin 2023: € 95,932 ▼ 52% vs 2022 (€ 199,720) Unfavourable step	€ 197,822 Gross margin 2024: € 197,822 ▲ 106% vs 2023 (€ 95,932) Favourable step	€ 116,120 Gross margin 2025: € 116,120 ▼ 41% vs 2024 (€ 197,822) Unfavourable step	▼ 41%
Profit after taxes	€ 129,898 Profit after taxes 2022: € 129,898 First fiscal year in the series	€ 53,066 Profit after taxes 2023: € 53,066 ▼ 59% vs 2022 (€ 129,898) Unfavourable step	€ 121,685 Profit after taxes 2024: € 121,685 ▲ 129% vs 2023 (€ 53,066) Favourable step	€ 59,238 Profit after taxes 2025: € 59,238 ▼ 51% vs 2024 (€ 121,685) Unfavourable step	▼ 51%
Equity	€ 655,827 Equity 2022: € 655,827 First fiscal year in the series	€ 567,336 Equity 2023: € 567,336 ▼ 13% vs 2022 (€ 655,827) Unfavourable step	€ 639,462 Equity 2024: € 639,462 ▲ 13% vs 2023 (€ 567,336) Favourable step	€ 574,227 Equity 2025: € 574,227 ▼ 10% vs 2024 (€ 639,462) Unfavourable step	▼ 10%
Total debts	€ 158,771 Total debts 2022: € 158,771 First fiscal year in the series	€ 275,706 Total debts 2023: € 275,706 ▲ 74% vs 2022 (€ 158,771) Unfavourable step	€ 244,192 Total debts 2024: € 244,192 ▼ 11% vs 2023 (€ 275,706) Favourable step	€ 266,875 Total debts 2025: € 266,875 ▲ 9% vs 2024 (€ 244,192) Unfavourable step	▲ 9%
Cash	€ 98,214 Cash 2022: € 98,214 First fiscal year in the series	€ 127,796 Cash 2023: € 127,796 ▲ 30% vs 2022 (€ 98,214) Favourable step	€ 556,317 Cash 2024: € 556,317 ▲ € 428,520 vs 2023 (€ 127,796) Favourable step	€ 612,933 Cash 2025: € 612,933 ▲ 10% vs 2024 (€ 556,317) Favourable step	▲ 10%
Land & buildings	€ 153,237 Land & buildings 2022: € 153,237 First fiscal year in the series	€ 197,385 Land & buildings 2023: € 197,385 ▲ 29% vs 2022 (€ 153,237) Unchanged	€ 194,356 Land & buildings 2024: € 194,356 ▼ 2% vs 2023 (€ 197,385) Unchanged	€ 189,957 Land & buildings 2025: € 189,957 ▼ 2% vs 2024 (€ 194,356) Unchanged	▼ 2%
Retained profit	€ 649,627 Retained profit 2022: € 649,627 First fiscal year in the series	€ 561,136 Retained profit 2023: € 561,136 ▼ 14% vs 2022 (€ 649,627) Unfavourable step	€ 633,262 Retained profit 2024: € 633,262 ▲ 13% vs 2023 (€ 561,136) Favourable step	€ 568,027 Retained profit 2025: € 568,027 ▼ 10% vs 2024 (€ 633,262) Unfavourable step	▼ 10%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 141,557 Dividend 2023: € 141,557 Unchanged (€ 0) Unchanged	€ 49,559 Dividend 2024: € 49,559 ▼ 65% vs 2023 (€ 141,557) Unchanged	€ 124,472 Dividend 2025: € 124,472 ▲ 151% vs 2024 (€ 49,559) Unchanged	▲ 151%
Bank debt	€ 116,664 Bank debt 2022: € 116,664 First fiscal year in the series	€ 108,083 Bank debt 2023: € 108,083 ▼ 7% vs 2022 (€ 116,664) Favourable step	€ 86,753 Bank debt 2024: € 86,753 ▼ 20% vs 2023 (€ 108,083) Favourable step	€ 76,100 Bank debt 2025: € 76,100 ▼ 12% vs 2024 (€ 86,753) Favourable step	▼ 12%
Balance sheet total	€ 814,597 Balance sheet total 2022: € 814,597 First fiscal year in the series	€ 843,042 Balance sheet total 2023: € 843,042 ▲ 3% vs 2022 (€ 814,597) Unchanged	€ 883,654 Balance sheet total 2024: € 883,654 ▲ 5% vs 2023 (€ 843,042) Unchanged	€ 841,102 Balance sheet total 2025: € 841,102 ▼ 5% vs 2024 (€ 883,654) Unchanged	▼ 5%

By gross margin, MEDISCH KABINET DR. LUC MOENS ranks 6th of 7 companies with main activity “Activiteiten van medisch specialisten” in Opwijk that publish figures (fiscal year 2025).

Key figures of MEDISCH KABINET DR. LUC MOENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about MEDISCH KABINET DR. LUC MOENS the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to MEDISCH KABINET DR. LUC MOENS?

What happened at MEDISCH KABINET DR. LUC MOENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 28, 2026 New annual accounts for financial year 2025: profit of € 59,238 (▼ 51% vs 2024). filed late Source: NBB ↗
2024 Luc Moens became a director. NBB
Jul 11, 2002 Start of the company according to the CBE. KBO